168 related articles for article (PubMed ID: 9389558)
1. Melanomas that develop within the eye inhibit lymphocyte proliferation.
Verbik DJ; Murray TG; Tran JM; Ksander BR
Int J Cancer; 1997 Nov; 73(4):470-8. PubMed ID: 9389558
[TBL] [Abstract][Full Text] [Related]
2. CD80-mediated induction of immunostimulation in two ocular melanoma cell lines is augmented by interferon-gamma.
Mulcahy KA; Alexander S; Platts KE; Wardle C; Sisley K; Rennie IG; Murray AK
Melanoma Res; 2002 Apr; 12(2):129-38. PubMed ID: 11930109
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
5. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes.
Fossati G; Taramelli D; Balsari A; Bogdanovich G; Andreola S; Parmiani G
Int J Cancer; 1984 May; 33(5):591-7. PubMed ID: 6233227
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
7. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
[TBL] [Abstract][Full Text] [Related]
8. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
[TBL] [Abstract][Full Text] [Related]
9. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma.
Rudy W; Gückel B; Siebels M; Lindauer M; Meuer SC; Moebius U
Int Immunol; 1997 Jun; 9(6):853-60. PubMed ID: 9199968
[TBL] [Abstract][Full Text] [Related]
10. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Hoon DS; Banez M; Okun E; Morton DL; Irie RF
Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
[TBL] [Abstract][Full Text] [Related]
12. Two antigens detected on human ocular melanomas with the mouse monoclonal antibodies 2/10SN and 10/12SN.
Safi N; Kantor RR; Atkinson B; Moratz C; Wilt AR; Pancake S; Reba R; Mathieson BJ; Desgrez A
Int J Cancer; 1992 Jul; 51(5):718-26. PubMed ID: 1612780
[TBL] [Abstract][Full Text] [Related]
13. T-cell recognition of HLA class II molecules induced by gamma-interferon on a colonic adenocarcinoma cell line (HT29).
Lundin KE; Sollid LM; Bosnes V; Gaudernack G; Thorsby E
Scand J Immunol; 1990 Apr; 31(4):469-75. PubMed ID: 2110380
[TBL] [Abstract][Full Text] [Related]
14. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
van Houdt IS; Sluijter BJ; Moesbergen LM; Vos WM; de Gruijl TD; Molenkamp BG; van den Eertwegh AJ; Hooijberg E; van Leeuwen PA; Meijer CJ; Oudejans JJ
Int J Cancer; 2008 Aug; 123(3):609-15. PubMed ID: 18498132
[TBL] [Abstract][Full Text] [Related]
15. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
[TBL] [Abstract][Full Text] [Related]
17. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
18. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
19. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
20. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
